Edition:
India

MediciNova Inc (MNOV.OQ)

MNOV.OQ on NASDAQ Stock Exchange Global Market

6.97USD
12:22am IST
Change (% chg)

$0.18 (+2.65%)
Prev Close
$6.79
Open
$6.80
Day's High
$7.04
Day's Low
$6.80
Volume
20,151
Avg. Vol
30,488
52-wk High
$7.85
52-wk Low
$4.40

Select another date:

Fri, Nov 10 2017

BRIEF-Medicinova announces collaboration

* Medicinova announces collaboration with the U.S. Department Of Veterans Affairs and Oregon Health & Science University to evaluate MN-166 (ibudilast) in methamphetamine use disorder

BRIEF-Medicinova announces positive top-line results from the Sprint-MS Phase 2B trial of MN-166 (ibudilast)

* Medicinova announces positive top-line results from the Sprint-MS phase 2B trial of MN-166 (ibudilast) in progressive MS: achieved both primary endpoints including a significant reduction in whole brain atrophy and safety and tolerability

BRIEF-Medicinova Inc files for potential mixed ‍​shelf of up to $200 million

* Medicinova Inc files for potential mixed ‍​shelf of up to $200 million - SEC filing Source text: [http://bit.ly/2fgDO2R] Further company coverage:

BRIEF-MediciNova completes enrollment in the phase 2 trial of MN-166 in methamphetamine dependence

* MediciNova announces the completion of enrollment in the phase 2 clinical trial of MN-166 (ibudilast) in methamphetamine dependence

BRIEF- MediciNova completes off-floor distribution

* Says it completes the off-floor distribution of shares on June 13

BRIEF- MediciNova to offer off-floor distribution of shares

* Says it will offer an off-floor distribution of 800,000 shares of its stock at the price of 602 yen per share, on the Tokyo Stock Exchange on June 13

BRIEF-MediciNova to offer off-floor distribution of shares

* Says it will offer an off-floor distribution of 800,000 shares on Tokyo Stock Exchange, from June 13 to June 15

Select another date: